Optomed
Optomed Plc is a Finnish medical technology company specializing in the research, development, manufacturing, and commercialization of handheld fundus cameras, artificial intelligence-based diabetic retinopathy screening software, and digital eye health solutions. The company produces innovative portable ophthalmic cameras and cloud-based AI diagnostic software utilized by hospitals, primary care clinics, and ophthalmology practices globally to detect eye diseases early. Its core business operations encompass medical device engineering, ophthalmic camera manufacturing, AI diagnostic software development, and global wholesale distribution. Revenue is derived directly from the global wholesale sale of fundus cameras, software licensing fees, and recurring SaaS subscription charges. Optomed holds a leading global market position in handheld fundus cameras and AI-powered eye screening technology. The company is headquartered in Oulu, Finland, and its shares trade on Nasdaq Helsinki.
3 of the funds FundTelligence covers report a position in Optomed.
- Legal name
- Optomed PLC
- Sector
- Health Care
- Country
- Finland
- Funds holding it
- 3
Funds holding Optomed
- Nordea Nordic Small Cap — Nordea Funds · 0.02 % (full portfolio disclosed, July 2026)
- Nordea Nordic Small Cap Fund — Nordea Funds · 0.02 % (full portfolio disclosed, July 2026)
- Handelsbanken Norden Index Criteria — Handelsbanken · 0.02 % (full portfolio disclosed, October 2026)